Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. RAPT
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
RAPT
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

RAPT Similar Chart Price Prediction

The price of RAPT is predicted to go up 0.46%, based on the high correlation periods with LARK. The similarity of these two price pattern on the periods is 92.63%.

stocks logo

RAPT

stocks logo

LARK

Up: 0.46%Similarity: 92.63%

RAPT Revenue Forecast

RAPT EPS Forecast

RAPT FAQs

What is bull’s view on RAPT?

RAPT Therapeutics (RAPT) has recently been upgraded to "Buy" by HC Wainwright with a price target of $10, reflecting a significant upside from its current price of $1.73. This bullish view is driven by the company's licensing agreement for RPT904, a promising anti-IgE monoclonal antibody targeting food allergies, and its potential to outperform existing treatments like omalizumab. Additionally, the $150 million private placement strengthens its financial position for upcoming clinical trials, enhancing investor confidence.

What is bear's view on RAPT?

RAPT Therapeutics (RAPT) recently received an upgrade from HC Wainwright to "Buy" with a price target of $10, significantly higher than its last closing price of $1.73. This bullish view is driven by optimism around its licensing agreement for RPT904 and potential in food allergy treatments. However, the stock remains speculative, with risks tied to clinical developments and regulatory milestones.

What is RAPT eps forecast for next quarter？

The market consensus for RAPT's eps in the upcoming quarter is projected to be approximately $0.10 USD.

RAPT VS S&P500

Ask Intellectia about RAPT

RAPT Analyst's Forecast

Yanan Zhu

Wells Fargo

Buy

2024-11-12

Price Target

$17 → $4

Upside

+129.89%

Wells Fargo analyst Yanan Zhu lowered the firm's price target on Rapt Therapeutics to $4 from $17 and keeps an Overweight rating on the shares. The firm notes the FDA took the most conservative stance asking for definitive proof regarding liver SAE, contrary to expert expectations. Wells further notes efficacy signal from Phase 2b, which bodes well for next-gen compound, and awaits data to assess potential.
Anupam Rama

JP Morgan

Hold → Sell

2024-11-11

Price Target

n/a

Downside

0%

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free

Hot Stocks

stocks logo

XRAY

DENTSPLY SIRONA Inc

$16.55
-3.50%
stocks logo

BL

Blackline Inc

$48.3
0.06%
stocks logo

PI

Impinj Inc

$96.66
5.74%
stocks logo

RARE

Ultragenyx Pharmaceutical Inc

$42.92
2.26%
stocks logo

GFF

Griffon Corp

$72.34
1.25%
stocks logo

NPO

Enpro Inc

$182.08
-2.11%
stocks logo

RUM

Rumble Inc

$9.32
1.53%
stocks logo

WRD

WeRide Inc

$19.95
0.61%
stocks logo

ALIT

Alight Inc

$6.83
0.89%
stocks logo

TCBI

Texas Capital Bancshares Inc

$79.16
0.73%